Iron as a co-morbid factor in nonhemochromatotic liver disease.
about
Hepatitis C genotype 4: The past, present, and futureIron increases HMOX1 and decreases hepatitis C viral expression in HCV-expressing cellsThe role of MR imaging in detection of hepatic iron overload in patients with cirrhosis of different origins.Associations among behavior-related susceptibility factors in porphyria cutanea tarda.Effect of hepatic iron concentration reduction on hepatic fibrosis and damage in rats with cholestatic liver diseaseLow-dose hydroxychloroquine is as effective as phlebotomy in treatment of patients with porphyria cutanea tarda.Iron levels in hepatocytes and portal tract cells predict progression and outcomes of patients with advanced chronic hepatitis C.Quantification of liver iron with MRI: state of the art and remaining challenges.Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases.HFE gene in primary and secondary hepatic iron overload.Lower serum hepcidin and greater parenchymal iron in nonalcoholic fatty liver disease patients with C282Y HFE mutations.Room-temperature susceptometry predicts biopsy-determined hepatic iron in patients with elevated serum ferritin.Relation between lipogranuloma formation and fibrosis, and the origin of brown pigments in lipogranuloma of the canine liver.Lymphocyte subsets in alcoholic liver disease.Role of alcohol in the regulation of iron metabolism.Iron homeostasis and H63D mutations in alcoholics with and without liver disease.Non-invasive assessment of liver fibrosis in chronic liver diseases: implementation in clinical practice and decisional algorithms.Body iron metabolism and pathophysiology of iron overload.Differences in hepatic phenotype between hemochromatosis patients with HFE C282Y homozygosity and other HFE genotypes.Disorders associated with systemic or local iron overload: from pathophysiology to clinical practice.Iron metabolism in Nonalcoholic Fatty Liver Disease.Porphyrin and heme metabolism and the porphyrias.Iron overload in myelodysplastic syndromes (MDS) - diagnosis, management, and response criteria: a proposal of the Austrian MDS platformNon-HFE iron overload as a surrogate marker of disease severity in patients of liver cirrhosis.Serum measures of iron status and HFE gene mutations in patients with hepatitis B virus infection.Hfe mutations and iron overload in patients with alcoholic liver disease.A corn oil-based diet protects against combined ethanol and iron-induced liver injury in a mouse model of hemochromatosis.Quantification of liver iron content with CT-added value of dual-energy.
P2860
Q26775815-926CA817-92B7-44DD-94CE-B63965C9BD04Q27489764-3FCE4598-7FE2-4A38-9C06-1255A99BD2D4Q33526884-8DFBE56F-0CF3-45FC-ADD0-66234DC920CCQ33712331-A50287A5-AB62-4556-8899-A41C467E46CFQ33788123-7CD04C33-BEB4-42A2-8E1C-93B6DC9B8AF6Q34300246-1E8925A9-42F5-4D8D-BB95-58C7F25E95E8Q34851479-11C016E8-57DC-4B55-8887-0C34BD39A9F9Q35020698-881888BF-52DD-40B3-90BA-0B40C28A4201Q35144263-FBFD9CC7-B48C-4F9A-B67F-AB04AE3D8D86Q36177897-54DFFC3F-7739-4F98-8DB9-3DF5FACE6844Q36293397-04591430-30BA-4490-9E05-6163C82BBC0BQ36401885-F514BBF1-18A2-44B2-8340-3EC748FEFC26Q36667561-B218EDFB-29E9-4EA8-B9B1-9A81B84C9A50Q36812841-1AC09AB9-F24B-4E60-B7BE-73638C471970Q36939980-6DD8C6A9-DE22-4704-80B9-014EFA3625CAQ37122115-88E79E06-82FB-496A-83D5-6CC0027E9EC1Q37192623-9624F8B0-FA17-4443-B11E-3AD893404C49Q37205002-6F1019AB-FCAC-4C29-ABC7-406AB8AF4668Q37237132-074C1495-73EE-45DB-8181-C682FE0F75BAQ37928941-2D1B9672-3897-4809-847D-A269A3F9951BQ37962398-DA62ED5B-264A-4EB8-97E0-839000083D9AQ38110514-237B6749-15EB-4E83-9C43-CDFD9DF49CB3Q39529378-8758B9A0-1460-4F09-A6A6-E1417E6D2255Q40912492-120100AB-EC10-400A-A107-670D2EB814CDQ45406186-20FB5878-839D-4080-821E-F2C099AEF569Q50190508-82B9C3BC-842E-4DBF-9E35-5700E1272FD5Q50931635-CDB76A9A-4FB1-40FD-8C2F-A29D14F364DDQ51581346-58192D79-DCF9-4A34-80CC-975CFFE5C0FD
P2860
Iron as a co-morbid factor in nonhemochromatotic liver disease.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Iron as a co-morbid factor in nonhemochromatotic liver disease.
@ast
Iron as a co-morbid factor in nonhemochromatotic liver disease.
@en
type
label
Iron as a co-morbid factor in nonhemochromatotic liver disease.
@ast
Iron as a co-morbid factor in nonhemochromatotic liver disease.
@en
prefLabel
Iron as a co-morbid factor in nonhemochromatotic liver disease.
@ast
Iron as a co-morbid factor in nonhemochromatotic liver disease.
@en
P2093
P1433
P1476
Iron as a co-morbid factor in nonhemochromatotic liver disease.
@en
P2093
Herbert L Bonkovsky
Richard W Lambrecht
P304
P356
10.1016/S0741-8329(03)00127-7
P577
2003-06-01T00:00:00Z